Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00511225 · ClinicalTrials.gov registry record · NA

Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease

A NA study of End Stage Renal Disease, sponsored by Creighton University.

Completed
Registry status
NA
Development phase
47
Enrollment target
1
Study location

NCT00511225 is a NA study of End Stage Renal Disease that has completed, run by Creighton University. The registered enrollment target is 47 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00511225, a NA study of End Stage Renal Disease, has completed, sponsored by Creighton University.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
1
Study location

Study Summary

Will oral vitamin improve strength, bone quality, pain and quality of life. This is a double blind, randomized placebo controlled study using 10,000 IU of cholecalciferol vs placebo.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT placebo
  • DIETARY_SUPPLEMENT cholecalciferol

Study Locations (1)

Nebraska

  • Creighton University - Omaha

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2007-09
Est. Completion 2011-09
Phase NA

Sponsor

Creighton University

98 total trials

What the Registry Record Tells You About NCT00511225

The ClinicalTrials.gov registry entry for NCT00511225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower). The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00511225 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT00511225 about?

NCT00511225 is a clinical study titled "Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease". Will oral vitamin improve strength, bone quality, pain and quality of life. This is a double blind, randomized placebo controlled study using 10,000 IU of cholecalciferol vs placebo.

What is the current status of trial NCT00511225?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2007-09. Estimated completion is 2011-09.

What conditions does trial NCT00511225 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT00511225?

The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), cholecalciferol (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00511225?

This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00511225 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.